NovaBridge Biosciences (NBP) Inventory Average (2022)
NovaBridge Biosciences (NBP) posted quarterly Inventory Average of $7.6 million for Q4 2022, down 99.64% quarter-over-quarter from $2.1 billion in Q2 2022.
Powered by 
Analysis
NovaBridge Biosciences (NBP) Inventory Average (2022) Analysis & Trends
NovaBridge Biosciences (NBP) has reported Inventory Average for 1 consecutive years, with $7.6 million the latest figure, recorded in Q4 2022.
- In Q4 2022, Inventory Average changed N/A year-over-year to $7.6 million; the TTM figure through Dec 2022 stood at $7.6 million (changed N/A YoY), while the FY2023 annual figure was $2.8 million, down 39.16% from the prior year.
- Inventory Average slipped to $7.6 million in Q4 2022 per NBP's latest filing, from $2.1 billion in the prior quarter.
- Across five years, Inventory Average topped out at $2.1 billion in Q2 2022 and bottomed at $7.6 million in Q4 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.51 Bn | 130.66 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.24 Bn | 77.25 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.28 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.89 Bn | 52.75 Bn | 52.00 Mn | 213.00 Mn |
| 5 | Revolution Medicines | 44.02 Bn | 44.02 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 707.10 Mn |
| 7 | Alnylam Pharmaceuticals | 35.49 Bn | 32.19 Bn | 992.69 Mn | 90.57 Mn |
| 8 | Royalty Pharma | 28.43 Bn | 27.59 Bn | - | - |
| 9 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 137.65 Mn |
| 10 | NovaBridge Biosciences | 199.33 Mn | 199.33 Mn | - | - |